These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21338431)

  • 1. The 'check effect' reconsidered.
    Rosen MI
    Addiction; 2011 Jun; 106(6):1071-7. PubMed ID: 21338431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does assigning a representative payee reduce substance abuse?
    Rosen MI; McMahon TJ; Rosenheck R
    Drug Alcohol Depend; 2007 Jan; 86(2-3):115-22. PubMed ID: 16839710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of public support payments to substance abuse among homeless veterans with mental illness.
    Frisman LK; Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):792-5. PubMed ID: 9175187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of representative payees on substance use by homeless persons with serious mental illness.
    Rosenheck R; Lam J; Randolph F
    Psychiatr Serv; 1997 Jun; 48(6):800-6. PubMed ID: 9175189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VA Disability Compensation and Money Spent on Substance Use Among Homeless Veterans: A Controversial Association.
    Tsai J; Rosenheck RA
    Psychiatr Serv; 2015 Jun; 66(6):641-4. PubMed ID: 25726979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.
    Ries RK; Dyck DG; Short R; Srebnik D; Fisher A; Comtois KA
    Psychiatr Serv; 2004 Apr; 55(4):445-7. PubMed ID: 15067161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability payments and chemical dependence: conflicting values and uncertain effects.
    Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):789-91. PubMed ID: 9175186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability payments, drug use and representative payees: an analysis of the relationships.
    Swartz JA; Hsieh CM; Baumohl J
    Addiction; 2003 Jul; 98(7):965-75. PubMed ID: 12814502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambiguity in determining financial capability of SSI and SSDI beneficiaries with psychiatric disabilities.
    Lazar CM; Black AC; McMahon TJ; O'Shea K; Rosen MI
    Psychiatr Serv; 2015 Mar; 66(3):279-84. PubMed ID: 25727116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring money mismanagement among dually diagnosed clients.
    Black RA; Rounsaville BJ; Rosenheck RA; Conrad KJ; Ball SA; Rosen MI
    J Nerv Ment Dis; 2008 Jul; 196(7):576-9. PubMed ID: 18626300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veterans' attitudes toward work and disability compensation: associations with substance abuse.
    Meshberg-Cohen S; Reid-Quiñones K; Black AC; Rosen MI
    Addict Behav; 2014 Feb; 39(2):445-8. PubMed ID: 24090622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness.
    Conrad KJ; Lutz G; Matters MD; Donner L; Clark E; Lynch P
    Psychiatr Serv; 2006 Feb; 57(2):197-204. PubMed ID: 16452696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after initial receipt of social security benefits among homeless veterans with mental illness.
    Rosenheck RA; Dausey DJ; Frisman L; Kasprow W
    Psychiatr Serv; 2000 Dec; 51(12):1549-54. PubMed ID: 11097652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe mental illness and substance use disorders among former Supplemental Security Income beneficiaries for drug addiction and alcoholism.
    Swartz JA; Lurigio AJ; Goldstein P
    Arch Gen Psychiatry; 2000 Jul; 57(7):701-7. PubMed ID: 10891041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterans who may need a payee to prevent misuse of funds for drugs.
    Rosen MI; Rosenheck RA; Shaner A; Eckman T; Gamache G; Krebs C
    Psychiatr Serv; 2002 Aug; 53(8):995-1000. PubMed ID: 12161675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case managers' and clients' perspectives on a representative payee program.
    Dixon L; Turner J; Krauss N; Scott J; McNary S
    Psychiatr Serv; 1999 Jun; 50(6):781-6. PubMed ID: 10375147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Social Security payments on substance abuse in a homeless mentally ill cohort.
    Rosen MI; McMahon TJ; Lin H; Rosenheck RA
    Health Serv Res; 2006 Feb; 41(1):173-91. PubMed ID: 16430606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.